Johanna W. Baars - Concepedia

Author

Johanna W. Baars

University of Amsterdam

Also Known As

J W Baars, J. W. BAARS, J. W. Baars, J.W. Baars, JW Baars, Johanna W. Baars

Publications

815

Citations

H-Index

Concepts

All Affiliations

University of Amsterdam Dutch Blood Transfusion Society

About

Johanna W. Baars is an author at University of Amsterdam specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	250
2	Immunology	6	6	236
3	Allergy	2	2	132
4	Health Sciences	1	1	60
5	Pathology	1	1	118

Johanna W. Baars

Publications

692

Citations

H-Index

Page 1

	Year	Citations
Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma Berthe M.P. Aleman, John Raemaekers, Umberto Tirelli, New England Journal of Medicine	2003	306
Activated Cytotoxic T Cells as Prognostic Marker in Hodgkin's Disease J J Oudejans, Natasha Jiwa, J. Alain Kummer, Blood	1997	136
Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway Gertjan Wolbink, J. Bollen, Johanna W. Baars, Journal of Immunological Methods Complement SystemImmunocytochemical TechniqueAllergyAutoimmune DiseaseImmunology	1993	118
Interleukin‐2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia Johanna W. Baars, Jan Paul de Boer, John Wagstaff, British Journal of Haematology Il-2 TherapyImmunologyPharmacotherapyIl-2 InfusionInflammation	1992	60
Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2 J. J. Heimans, John Wagstaff, W. O. Schreuder, Surgical Neurology OphthalmologyLeptomeningeal CarcinomatosisImmunologyContinuous Intraventricular InfusionImmunotherapy	1991	23
Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2) Johanna W. Baars, John Wagstaff, C.E. Hack, Annals of Oncology InflammationRheumatologyAllergyVasculitisAutoimmune Disease	1992	14
Treatment with tumour infiltrating lymphocytes and interleukin-2 in patients with metastatic melanoma: A pilot study Johanna W. Baars, J. C. M. Fonk, R.J. Scheper, Biotherapy Tumor ImmunologyCancer ImmunosurveillanceSkin CancerMedicineMelanoma	1992	12
The release of interleukin-8 during intravenous bolus treatment with interleukin-2 Johanna W. Baars, Gertjan Wolbink, M. Hart, Annals of Oncology InflammationImmunosuppressive TherapyImmunologyHematologyImmunosuppression	1994	12
Phase I Study on the Sequential Administration of Recombinant Human Interferon- and Recombinant Human Interleukin-2 in Patients With Metastatic Solid Tumors Johanna W. Baars, John Wagstaff, E. Boven, JNCI Journal of the National Cancer Institute ImmunologyImmunoeditingImmunotherapeuticsImmunotherapyFree University Hospitalamsterdam	1991	11

Page 1